Compare PHIN & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHIN | AXGN |
|---|---|---|
| Founded | 2023 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 2023 | 2013 |
| Metric | PHIN | AXGN |
|---|---|---|
| Price | $57.16 | $34.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $91.60 | $53.67 |
| AVG Volume (30 Days) | 381.2K | ★ 1.3M |
| Earning Date | 10-29-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | ★ 84.09 | N/A |
| EPS | ★ 2.01 | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $4.59 | $26.82 |
| Revenue Next Year | $3.61 | $28.63 |
| P/E Ratio | $28.74 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $51.28 | $16.79 |
| 52 Week High | $86.94 | $52.91 |
| Indicator | PHIN | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 34.39 | 27.16 |
| Support Level | N/A | $30.29 |
| Resistance Level | $81.54 | $36.00 |
| Average True Range (ATR) | 1.49 | 1.40 |
| MACD | 0.21 | -0.18 |
| Stochastic Oscillator | 32.38 | 4.97 |
Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, it generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.